Back to top

Tango Therapeutics initiated with an Overweight at JPMorgan

JPMorgan analyst Brian Cheng initiated coverage of Tango Therapeutics (TNGX) with an Overweight rating and $46 price target The firm says Tango is ...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Tango Therapeutics, Inc. (TNGX)